Clinical Trial Update: Corneal Findings in Patients Treated With Belantamab Mafodotin

View source ↗

Summary

A clinical trial update notes corneal findings in patients treated with belantamab mafodotin and indicates the associated trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Belantamab Mafodotin (belantamab mafodotin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Multiple Myeloma, Corneal Diseases | Status: TERMINATED